Le Lézard
Classified in: Health
Subject: MRR

Intermittent Catheters Market size is set to grow by USD 1.22 billion from 2024-2028, Increasing incidence of urinary incontinence coupled with aging population boost the market, Technavio


NEW YORK, Aug. 9, 2024 /PRNewswire/ -- The global intermittent catheters market size is estimated to grow by USD 1.22 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of almost 7.25% during the forecast period. Increasing incidence of urinary incontinence coupled with aging population is driving market growth, with a trend towards growing focus of vendors toward using advanced biocompatible materials. However, risks/complications associated with intermittent catheters poses a challenge. Key market players include ASID BONZ GmbH, At Home Medical Products Inc., B.Braun SE, Becton Dickinson and Co., Cardinal Health Inc., Catheter Medical, Coloplast AS, COMFORT MEDICAL LLC, CompactCath Inc., ConvaTec Group Plc, Dentsply Sirona Inc., Hollister Inc., HR Pharmaceuticals Inc., McKesson Corp., Medline Industries LP, Optimum Medical Ltd., Paralogic Pty Ltd, Pennine Healthcare, Romsons, and Teleflex Inc..

Get a detailed analysis on regions, market segments, customer landscape, and companies- View the snapshot of this report

Intermittent Catheters Market Scope

Report Coverage

Details

Base year

2023

Historic period

2018 - 2022

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 7.25%

Market growth 2024-2028

USD 1221 million

Market structure

Fragmented

YoY growth 2022-2023 (%)

6.77

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 62%

Key countries

US, Italy, Germany, Japan, and Finland

Key companies profiled

ASID BONZ GmbH, At Home Medical Products Inc., B.Braun SE, Becton Dickinson and Co., Cardinal Health Inc., Catheter Medical, Coloplast AS, COMFORT MEDICAL LLC, CompactCath Inc., ConvaTec Group Plc, Dentsply Sirona Inc., Hollister Inc., HR Pharmaceuticals Inc., McKesson Corp., Medline Industries LP, Optimum Medical Ltd., Paralogic Pty Ltd, Pennine Healthcare, Romsons, and Teleflex Inc.

Market Driver

The Intermittent Catheter Market is witnessing significant growth due to the increasing prevalence of urinary diseases such as urinary tract infections, urethral obstructions, renal diseases, tumors, and neurogenic bladder. The market includes two main product types: uncoated intermittent catheters and coated intermittent catheters. Uncoated catheters have smooth, slippery surfaces, making them suitable for individuals with urethral trauma or tissues. Coated catheters, on the other hand, have antimicrobial or hydrophilic coatings, which help prevent urinary tract infections and make catheterization easier. Hospitals, ambulatory surgical centers, and medical research centers are key end-users. Technological advancements, such as the development of hydrophilic intermittent catheters, are driving market growth. Reimbursement schemes and government initiatives for the aging population with disabilities, such as spinal cord injuries, are also boosting demand. Global prevalence of urinary diseases among adult Americans is high, and CXOs in the healthcare industry are focusing on catheter design and materials to improve patient comfort and outcomes. 

Discover 360° analysis of this market. For complete information, schedule your consultation - Book Here!

Market Challenges

For more insights on driver and challenges - Request a sample report!

Segment Overview 

This intermittent catheters market report extensively covers market segmentation by 

  1. End-user 
    • 1.1 Hospitals
    • 1.2 Ambulatory surgery center
    • 1.3 Medical research center
  2. Product 
    • 2.1 Uncoated intermittent catheters
    • 2.2 Coated intermittent catheters
    • 2.3 Closed system intermittent catheters
  3. Geography 
    • 3.1 North America
    • 3.2 Europe
    • 3.3 Asia
    • 3.4 Rest of World (ROW)

1.1 Hospitals- The intermittent catheter market is experiencing significant growth due to the increasing prevalence of chronic kidney diseases (CKD) and the expansion of digital catheterization laboratories in hospitals. Hospitals are expected to dominate the market share due to the high demand for intermittent catheters in providing quality patient care. However, the rise of self-catheterization may hinder market growth. Notably, the number of catheterization laboratories is increasing in the region, leading to market expansion. The hospital segment's growth is driven by the high demand for intermittent catheters, making it a key contributor to the market's growth during the forecast period.

For more information on market segmentation with geographical analysis including forecast (2024-2028) and historic data (2017-2021) - Download a Sample Report

Learn and explore more about Technavio's in-depth research reports

The global urinary catheters market is poised for robust growth, driven by increasing prevalence of urinary disorders and advancements in catheter technology. Innovations in catheter materials and designs are enhancing patient comfort and reducing infection risks. Similarly, the global thoracic catheters market is expanding due to rising cases of thoracic diseases and surgical procedures. Improved thoracic catheter technologies are boosting market growth, providing better patient outcomes and safety. Both markets are expected to see significant advancements and increased adoption in the coming years.

Research Analysis

The Intermittent Catheter market refers to the segment of medical devices used for the drainage of urine from the urinary bladder. These catheters are typically made of materials like Polyvinyl Chloride (PVC), vinyl, or silicone, and come in one-time use or reusable versions. Indications for use include urinary bladder emptying in individuals with spinal cord injuries or urinary incontinence. The rise in urinary tract infections and the growing geriatric population are driving the market's growth. However, price competition and lack of awareness are challenges.

Table of Contents:

1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation

7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio


These press releases may also interest you

at 11:12
Warrior Care Network®, a partnership between Wounded Warrior Project® (WWP) and four leading academic medical centers, will receive the 2024 Sarah Haley Memorial Award for Clinical Excellence by the International Society of Traumatic Stress Studies....

at 11:10
The Board of Certification for Emergency Nursing (BCEN), the benchmark for...

at 11:05
A team of researchers from City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S., and The University of Texas M.D. Anderson Cancer Center, have reported safety and efficacy results from a Phase 1...

at 11:02
CVS Health has announced that its board of directors has approved a quarterly dividend of sixty-six and one-half cents ($0.665 cents) per share on the Common Stock of the Corporation. The dividend is payable on November 1, 2024, to holders of record...

at 11:01
The Healthcare Businesswomen's Association (HBA) has appointed Varduhi Kyureghyan as Chief Financial Officer (CFO). In this role, she will lead financial management and oversight of the global association dedicated to advancing the impact and...

at 11:00
Recharge, the leading subscription platform, today announced that quip, the design-led oral health and wellness company on a mission to make every mouth healthy, has migrated its subscription program to the Recharge platform. quip has built its brand...



News published on and distributed by: